3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Gender: Female -

Hormone aids conception in women with endometriosis

Gender: FemaleJan 31, 06

For women with endometriosis who undergo assisted fertilization procedures, treatment with a hormone that decreases the body’s production of testosterone and estrogen a few months before the procedure quadruples the chance of successful pregnancy, according to a review of randomized trials—but data on side effects is lacking.

Endometriosis is a painful condition that occurs when the tissue that normally lines the uterus grows outside the uterus, often in pelvic and abdominal areas were it is not supposed to grow. Endometriosis is a leading cause of infertility—up to 40 percent of women with this condition are unable to conceive.

Dr. Hassan Sallam, from Alexandria University in Egypt, and colleagues used medical databases and reports from major reproductive medicine meetings to look for studies that used pretreatment with gonadotropin-releasing hormone (GnRH) agonists as a way to improve pregnancy rates in endometriosis patients who underwent in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Three trials with a total of 165 women were included in the analysis, which is published in the online issue of The Cochrane Library.

Women pretreated with a GnRH agonist were 4.28-times more likely to become pregnant than their untreated peers, the report indicates. Moreover, the results of one of the studies indicated a 9.19-fold increase in the live birth rate with use of this strategy.

The effect, if any, of GnRH agonist therapy on miscarriage rates is unclear, because just two of the studies examined this outcome, the authors point out. Similarly, there were insufficient data to reach any conclusions about the impact of this treatment on multiple or ectopic pregnancies, fetal anomalies, or other complications.

The message “from these three trials is that the administration of GnRH agonists for a period of three to six months prior to IVF or ICSI in women with endometriosis increases the odds of pregnancy by more than fourfold,” the researchers conclude.

SOURCE: The Cochrane Library, January 25, 2006.

Print Version
comments powered by Disqus

  What’s the life expectancy of patients when they begin treatment for osteoporosis?
  Addressing the needs of young women with disorders of sex development
  Study ties breathing problems, asthma to bone loss
  Arkansas to appeal ruling on abortion restriction law
  Supreme Court declines to hear new contraception cases
  Optimism linked to healthier eating among women
  Lactation consultants can boost breastfeeding
  Sexual function dramatically improves in women following bariatric surgery, Penn study finds
  Arkansas governor vetoes bill banning abortions at 20 weeks
  In Vitro Fertilization Less Successful With Alternative Fertility Treatments
  House GOP look to reshape birth control debate
  Online dating research shows cupid’s arrow is turning digital


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site